Detalhe da pesquisa
1.
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms.
Blood
; 141(8): 917-929, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356299
2.
Impaired virus-specific T cell responses in patients with myeloproliferative neoplasms treated with ruxolitinib.
Hematol Oncol
; 38(4): 554-559, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32583904
3.
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature.
Br J Haematol
; 201(2): 353-356, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36793194
4.
Molecular remission is an independent predictor of progression-free survival in patients with Waldenström macroglobulinemia treated with chemo-immunotherapy: Results from the FIL_BIOWM study.
Hematol Oncol
; 41(3): 574-577, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36218059
5.
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis.
Blood
; 123(15): 2416-9, 2014 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24553179
6.
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.
Blood
; 124(7): 1062-9, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24986690
7.
Prognostic impact of somatic mutations on time to first treatment: Results of targeted next-generation sequencing in 211 patients with early stage chronic lymphocytic leukemia.
Am J Hematol
; 96(11): E404-E408, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34329489
8.
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group.
Am J Hematol
; 95(1): E1-E3, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31588594
9.
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.
Blood
; 119(1): 188-91, 2012 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22072557
10.
Ruxolitinib treatment and risk of B-cell lymphomas in myeloproliferative neoplasms.
Am J Hematol
; 94(7): E185-E188, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30972817
11.
Facing erythrocytosis: Results of an international physician survey.
Am J Hematol
; 94(9): E225-E227, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31148218
12.
LNK mutations in familial myeloproliferative neoplasms.
Blood
; 128(1): 144-5, 2016 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27216218
13.
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project.
Haematologica
; 103(9): e392-e394, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29622658
14.
Pregnancy outcome and management of 25 pregnancies in women with polycythemia vera.
Am J Hematol
; 93(9): E234-E235, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29989197
15.
Eosinophilic dermatosis of hematologic malignancy in patients with chronic lymphocytic leukemia/non-Hodgkin's B lymphoma: a single center prospective clinico-pathological study.
Front Med (Lausanne)
; 10: 1231003, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37614953
16.
Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia.
Blood
; 124(16): 2611-2, 2014 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25323688
17.
Evaluating ibrutinib for the treatment of relapsed/refractory marginal zone lymphoma.
Expert Opin Pharmacother
; 22(13): 1643-1649, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120550
18.
Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?
Blood Adv
; 5(24): 5490-5500, 2021 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34525181
19.
Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia.
Haematologica
; 100(11): e443-5, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26250575
20.
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene.
Ann Hematol
; 94(11): 1927-8, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26202607